Working and treatment of Memantine - Namenda Prescription drug
Home       Treatment        Side Effects       Eli Lilly       FDA Aproval

 

Working and treatment of Memantine - Namenda
Memantine is an oral medication for treating patients with Alzheimer disease. Acetylcholine and acetyl cholinesterase are the important enzymes in the body, which lead to the situation of Alzheimer’s. Memantine effects independently in the Acetylcholine and acetyl cholinesterase. Glutamate is the main neuron transmitter in the brain.

This glumate is mainly responsible for the de generation of these nerves, which make some neurological diseases like Alzheimer's. Like any other neuron transmitter, glumate also produce and release the nerve cells in the brain. Then these released glumate travel to near by nerves cells, which is attached with a receptor. So avoiding the growth of glumate is helpful for avoiding the neurological diseases like Alzheimer's. Memantine block these receptors which helpful to decrease the effect of glumate. Other than this Memantine or Namenda also protect nerve cells from excess stimulation by glumate.

The doctor prescribes Memantine to a patient after conducting so many tests. This helps them to identify whether the patients have any problem with the Memantine or Namenda. The children aged below 13 is not allowed to take the Memantine. The people who are above 60 can take the medicine according to the doctor prescriptions. The patients who are having kidney disease, seizures (convulsions) or a seizure disorder, an unusual reaction to Memantine, other medicines, foods, dyes, or preservatives, pregnant or trying to get pregnant are not allowed to take the Memantine or Namenda. The Memantine is also excreted in the breast milk. So the patient who is in breast feeding is also restricted to take the Memantine.
 
Home       Treatment        Side Effects       Eli Lilly       FDA Aproval